Introduction
Two years have passed since the appearance of the Ž focused issue on signal transduction Cardiovascular Re-. search, volume 30, issue 4, October 1995 . In that issue a selection of topics related to cardiovascular signal transduction were highlighted. Since then a wealth of new information has deepened our insight into the factors that govern the activity of the different signal transduction pathways. Moreover, the importance of cross-talk between signal transduction pathways is being recognized and has, at the same time, made us aware of the complexity of the signal transduction network. Finally, new players in the field of cardiovascular signal transduction have emerged, the most striking example being the Stress-Activated Protein Kinases.
The purpose of this review is to summarize these new developments in this area of research. Considering the rate with which the various signal transduction pathways and their interrelationships are being deciphered the task of writing an update that pays tribute to all these new insights and developments is virtually impossible. Accordingly, as a major theme of this review the recent developments on angiotensin II-mediated signal transduction was chosen. This choice is not entirely arbitrary. In the October 1995 issue on cardiovascular signaling the role of angiotensin II Ž . Ang II was a main topic of various reviews already w x 1-3 . More importantly Ang II, either systemic or locally produced, is considered to play a pivotal role in cardiovascular adaptation. Signaling via this peptide growth factor involves various receptor subtypes and results in the activation of a variety of signal transduction cascades, which have been unravelled to a large extent over the past couple of years.
Mechanical forces and signal transduction
The major type of mechanical force to which the cardiac muscle is subjected is cyclic stretch. In contrast, the Ž vascular endothelial cells face both cyclic stretch pres-. Ž . sure and shear forces blood flow . It is generally accepted that mechano-sensing is of paramount importance in the activation of signal transduction pathways in endothelial cells, vascular smooth muscle cells, and cardiac muscle cells, that enable the cardiovascular system to w x adjust to changing demands 4,5 . Nevertheless the precise mechanism of cellular mechano-sensing remains to be elucidated. To date three major hypotheses have been put forward to pinpoint the molecular basis of mechano-sensing. According to the first hypothesis mechanical stimuli w x are sensed by stretch-activated ion channels 6,7 . Patch clamp analysis has shown that these channels behave like non-selective cation channels that can be blocked by gadolinium. Second it has been proposed that the molecu-Ž . lar components of the extracellular matrix ECM and w x cytoskeleton are responsible for mechano-sensing 8 . In this context the role of the family of proteins referred to as Ž . integrins and so-called focal adhesion kinases FAK have w x received widespread attention 9,10 . The integrins have been thought to act as transmembrane mechanoreceptors. FAK possesses tyrosine kinase activity and becomes activated when a cell makes contact with the extracellular w x matrix 11 . Whatever the nature of the mechano-receptors, there is ample evidence to support the notion that Time for primary review 31 days.
( )mechano-transduction provides the initial trigger for Ž . short-term cardiac contractility, vascular tone as well as Ž long-term adaptive responses cardiac and vascular remod-. eling in the cardiovascular system. The third hypothesis is based on the experimental observation that applying a mechanical stimulus to most cell types leads to the synthesis of a whole range of autocrine and paracrine factors that, in turn, are able to modulate the activity of various signal transduction pathways. Hence, according to this hypothesis the question as to how mechanical signals are conveyed to the cells interior, can be narrowed down to the question as to how the synthesis of these growth factors is induced in response to mechanical stimuli. In this sense the latter hypothesis does not provide a true mechanistic explanation for mechano-sensing.
Imposing shear stress to endothelial cells has been shown to lead to the formation of, amongst others, en-Ž . Ž . dothelin-1 ET-1 , basic fibroblast growth factor bFGF , Ž . w x and Nitric Oxide NO 12,13 . Stretch of cardiac myocytes has been shown to induce the synthesis and release Ž . w x of Angiotensin II Ang II 7 . In addition, increased Ž . synthesis of transforming growth factor-b TGFb and Ž . endothelin-1 ET-1 , either directly as a result of the mechanical stimulus or secondary to the effects of stretchw x induced Ang II production, have been reported 14,15 . Each of these factors has been shown to induce changes in gene expression in primary cultures of neonatal cardiac myocytes that are reminiscent of the hypertrophic response w x of the heart in situ 16,17 .
Systemic and local angiotensin II
Ang II is the biologically most active component of the renin angiotensin system. The physiological effects of circulating Ang II, such as its involvement in blood pressure control, aldosterone release and water balance, are relatively well known. Only recently the biological significance of locally produced Ang II is being acknowledged. It has become apparent that the cardiac tissue itself expresses all components of the renin angiotensin system, i.e. renin, angiotensinogen, and angiotensin converting enzyme and that the expression of these components alters under pathow x physiological conditions, like cardiac hypertrophy 18 . Induction of cardiac hypertrophy in rats in situ by supra-renal constriction of the aorta has been shown to increase circulating levels of Ang II, in addition to the upregulation of the expression of components of the renin angiotensin system in the heart, suggesting activation of the intracarw x diac renin angiotensin system 19 . In addition, cyclic stretch of cardiac myocytes has been shown to upregulate w x the activity of the angiotensinogen promoter 20 and w x elicits release of Ang II into the surrounding medium 7 . These findings support the notion that the intracardiac renin angiotensin system is of functional importance. The biological significance of Ang II is further illustrated by the fact that addition of a specific type I Angiotensin receptor antagonist to the culture medium prevents the effects of mechanical stimuli on cardiomyocyte phenotype w x 21 . Accordingly, when evaluating the effects of Ang II in situ both changes in circulating levels and local production have to be taken into account. Divergent effects of Ang II at the systemic and tissue level have been reported by the w x group of Delafontaine 22, 23 , who showed that venous infusion of Ang II in rats reduces Insulin like Growth Ž . Factor 1 IGF-1 levels in the circulation, while at the same time increasing IGF-1 mRNA levels in the heart.
Angiotensin II receptors
Ligand binding studies have revealed the existence of at least two Angiotensin II receptor subtypes, referred to as Ž . Ž . the angiotensin receptor type I AT and type II AT , cardiac hypertrophy and failure various groups were unable to detect changes in AT or AT receptor mRNA 1 2 w x levels 31,32 , whereas others reported downregulation w x w x 33,34 or upregulation 25 of the AT receptor. Also in 1 the human failing heart the AT receptor mRNA level was 1 found to decline, whereas that of the AT receptor was 2 w x unaltered 35 . The discrepancies observed are probably related to species differences and to differences in the Ž experimental models used pressure-versus volume-overload, compensated versus decompensated hypertrophy, . etc. . In addition, it is feasible that time-dependent changes in receptor-subtype expression are also involved. Whatever the exact cause, these findings indicate that the modulation of angiotensin II receptor subtype density, and consequently the activation of partly different downstream signal transduction pathways, provides another level of regulation with respect to Ang II signaling. Further complexity is added to the system by AT receptor desensitization, which has been shown to occur rapidly following ligand w x binding 36 . Circumstantial evidence indicates that protein Ž . kinase C PKC -mediated phosphorylation events may be involved in the desensitization of receptors. However, a role of PKC in AT receptor desensitization could not be w x demonstrated 36 .
The AT receptor 2
Given the predominance of AT receptors in the human 2 w x heart 27 and the observed changes in relative abundance of the AT and AT receptor subtypes under various 1 2 Ž . pathological conditions described above a more detailed knowledge of the AT receptor and its downstream signal-2 ing pathways is of primary importance. However, current knowledge on AT receptor-mediated signaling is scarce 2 w x 37 . Despite its structural identification as a G-proteincoupled seven-transmembrane receptor, analysis of putative downstream signaling pathways in human embryonic kidney cells overexpressing the AT receptor did not 2 provide evidence for its coupling to typical G-protein w x mediated signaling mechanisms 38 . However, more recent findings based on immunochemical techniques indicate that the AT receptor specifically interacts with Ga i . might be linked to protein kinase C PKC , as the translocation of PKC from the soluble to particulate fraction was inhibited by PD123319, a specific AT -receptor antagonist. Again it is important to stress that presenting these pathways as individual cascades is necessary for the sake of clarity, but does not pay tribute to the complexity of the cellular response, in which various factors involved in 'one' cascade are part of, andror influence, other cascades.
InÕolÕement of different phospholipase C-isoforms
To date as many as 10 phosphoinositide-specific phos-Ž . pholipase C PLC isozymes have been identified. These isozymes can be subdivided into three subclasses, i.e., PLC-b, PLC-g and PLC-d on the basis of sequence how x mologies and certain motifs in their catalytic domain 45 . The mode of activation of the d-isozymes is largely unknown. The activity of PLC-b isozymes is modulated by w x G-proteins 46 , whereas PLC-g isozymes contain so-called Ž . SH2 Src-homology domains that allow them to interact w x with tyrosine phosphorylated receptors 47 . The functional importance of the different isoforms is illustrated by the fact that knock-out of the gene encoding PLC-g1 resulted in embryonic lethality, thereby demonstrating that at this developmental stage other PLC-isozymes obviously can w x not functionally compensate for this specific isozyme 48 .
As the AT receptors are G-protein-coupled receptors it 1 was first believed that PLC-b was the isozyme most likely Ž . involved in the downstream signaling pathways Fig. 1 . However, recent findings strongly support the notion that, in addition to PLC-b, PLC-g is an important downstream effector of the AT receptor. As the AT receptor lacks 1 1 intrinsic tyrosine kinase activity, the issue of how this type of receptors is linked to tyrosine kinase pathways has been Ž a key question, which by now has largely been solved see . below .
G-proteinr PLC-b mediated signaling
The role of G-proteins in cardiac signal transduction w x was extensively reviewed by Brodde et al. 49 . The ( )G-proteins act as coupling proteins that become activated upon receptor stimulation. In its GDP-bound form the protein forms an inactive heterotrimer composed of an a-, b-, and g-subunit associated with the receptor. Upon ligand binding conformational changes in the receptor are transmitted to the a-subunit resulting in the release of GDP and its replacement by GTP. Subsequently, the aand the bg-subunits become dissociated and are released from the receptor. Both the a-subunit and bg-subunit are w x able to activate target systems 50 . As reviewed by Brodde w x and coworkers 49 the G-proteins are classified on the basis of their Ga-subunit. Three major subfamilies of G-proteins can be distinguished, Ga s, Ga i, and Ga q, which couple to different sets of receptors. The AT , 1 a -adrenergic and endothelin-1 receptor make use of Gq. VSMC. These and other findings point to a functional link between the AT receptor and PLC-g. Indeed, stimulation 1 of VSMC with Ang II resulted in the tyrosine phosphorylation of PLC-g1. Just recently the molecular link between G-protein-coupled receptors and tyrosine phosphorylation of PLC has been elucidated. Members of the Src-family of tyrosine kinases were considered likely candidates as in vitro studies had already shown that PLC-g is a good w x substrate for this family of kinases 54 . Subsequent studies have provided firm evidence that Src is part of the pathway that couples Ang II with PLC-g. It has been shown that Ang II administration leads to a rapid activation of Src w x in VSMC 55 and that anti-Src antibodies, introduced into the intracellular milieu of VSMC by electroporation, substantially reduced PLC-g phosphorylation and IP produc-3 w x tion following Ang II stimulation 56 . In a recent paper w x Schelling and coworkers 57 challenged the notion that PLC-g is the principal PLC isozyme involved, as they were able to demonstrate the presence and functional significance of PLC-b1 in vascular smooth muscle cells of rat and human origin.
Protein kinase C
PKC's are serinerthreonine kinases that can be classified into those isoforms that are phosphatidylserine, Ca 2q , Ž DAG or phorbolester-dependent the 'classical' cPKC a , .
nPKC's , and those that require neither Ca nor DAG for Ž .w x activity the 'atypical' aPKC's 58 . Diacylglycerols Ž . DAG are considered the classical lipidic activators of PKC. However, recent findings indicate that polyunsaturated fatty acids, either alone or in synergy with DAG, also Ž act as modulators of the different PKC isoforms Van w x w x. Bilsen 59 and references herein, 60,61 . However, the significance of fatty acids as modulators of PKC activity in vivo still remains to be established. Furthermore, evidence has been obtained that the chemical nature of the phospholipid substrate may also be of importance. Musial et al. w x 62 showed that stimulation of mesangial cells with ET-1 led to the formation of DAG derived from ester-linked phospholipids, whereas in the case of interleukin-1a Ž . ether-linked phospholipids plasmalogens were preferentially used as substrate. These plasmalogen-derived DAG w x may act as inhibitors rather than activators of PKC-a 62 .
Over the past couple of years various research groups have tried to establish which PKC isoforms are present in the different cell types within the cardiovascular system ( )Ž w x . see 63,64 for reviews . The general picture emerging from these studies is that each cell type is equiped with a more or less unique combination of 'classical', 'novel' and 'atypical' PKCs. For instance, within the cardiomyocyte there is more or less consensus about the presence of PKC-a, -d, -e, -z, and -h, whereas the presence of PKC-b could not be confirmed in all studies. In contrast to myocytes, PKC-b is abundantly present in vascular smooth muscle cells and endothelial cells and considered to be of special functional relevance under various pathophysiological conditions. For instance, activation of PKC-b has been w x implicated in the vascular pathology of diabetes 65,66 .
It is generally assumed that the activation of distinct PKC's results in the activation of different sets of downstream targets. The role of individual PKC isoforms in cardiovascular disease, with special emphasis on their w x mode of activation 67 and changes in their subcellular w x translocation in response to external stimuli 68 , is still matter of intensive research. In this respect the role of so-called anchoring proteins, previously thought to be involved in protein kinase A signaling only, deserves w x attention 69 . These proteins assist in the sequestration of signaling units at discrete sites within the cell. Developmental changes in PKC-isoform expression andror activw x ity have been reported by a number of groups 70-73 . In addition, it was recently shown that heart failure induced by a sequential volume-and pressure-overload was associated with reduced protein levels of PKC-a, -b1, -g, and w x -e, whereas the PKC-z remained unaltered 74 . Stimulation of neonatal cardiomyocytes with an a -adrenergic 1 agonist caused translocation of PKC-d and PKC-e, but not of PKC-a, from the soluble to membrane-associated fracw x tion 67 . Likewise, stimulation of these cells with either phenylephrine or ET-1 was associated with the activation w x of different sets of PKC isoforms 75 . On the other hand, the observation that transfection of neonatal myocytes with either cPKC-a, nPKC-e, or aPKC-z was equally effective w x in activating the ANF-promoter 76 is not in favor of a divergent role of the distinct PKC isoforms.
Many studies, using either more or less specific syn-Ž . thetic activators phorbolester or related analogues or Ž . inhibitors staurosporin, H7 have demonstrated the importance of PKC-mediated signaling in the regulation of Ž . processes as contractile protein function and pathological Ž w x . cell growth see 52,77 for reviews . In view of the importance of the PKC-family it is actually surprising that relatively little is known about its target proteins. One of the major target proteins of PKC within the heart is the M yristoylated Alanine-Rich C-Kinase Substrate Ž . w x MARCKS 73 . The function of this ubiquitously expressed protein is largely unknown, although research on cancer has provided some indications that it may play a role in cell proliferation. It is generally accepted that PKC Ž feeds into the mitogen activated protein kinase MAPK, . also referred to as ERK1r2 pathway, which acts as a convergence point for several signaling pathways.
A number of studies were designed to examine which PKC-isoforms become activated upon Ang II stimulation. From the discussion above it will be apparent that this response is likely to be cell type specific. In COS cells stably transfected with the AT receptor the addition of 1 Ang II led to the translocation of the a-and e-isoforms, w x but not of the b-, g-, or d-isoforms of PKC 78 . Liao and w x coworkers 79 provided evidence that in cultured vascular smooth muscle cells the atypical PKC-z isozyme is responsible for the activation of MAPK by Ang II. Indeed transfection with PKC-z antisense oligonucleotides specifically downregulated PKC-z protein expression, and blunted the effect of Ang II on MAPK activation. has also w x been demonstrated 95,96 . Upon phosphorylation Elk-1 translocates from the cytoplasm to the nucleus, where it forms a ternary complex with the serum response factor Ž .
X SRF and the serum response element in the 5 -untranslated regions of several genes, among which the immediate early gene c-fos. The ternary complex enhances transcripw x tion of the c-fos gene 96 .
In conclusion, stimulation of a wide variety of G-protein-coupled receptors that lack intrinsic tyrosine kinase activity, including the AT receptor, indirectly leads to the 1 activation of MAPK in a process involving tyrosine phosphorylation. The G-protein-coupled receptors share this property with the family of cytokine receptors. This notion has provided great impetus for the research into the role of cytokines in cardiovascular signal transduction and the relation between Ang II and cytokine-mediated signaling in recent years.
Signaling through p21 Ras
In view of the important role of Raf in signal transduction, the biological significance of p21 Ras, one of the activator proteins of Raf, in signal transduction in the cardiovascular system has also received widespread attention. Activated p21 Ras, a low molecular weight GTP-binding protein, recruits Raf to the cell membrane. In addition to phosphorylation, this is one of the ways by which Raf activity is regulated. Various hypertrophic agonists w x have been shown to activate p21 Ras 97 . Similar to the effects of Ga q, microinjection of constitutively active mutants of Ras induced ANF expression and neutralizing antibodies against Ras prevented ANF expression in cells w x following a-adrenergic stimulation 97 .
The exact nature of the link between the G-protein-coupled receptors and p21 Ras has not been solved definitively. Current evidence indicates that the activation of p21 Ras is not the result of Gq activation, but rather occurs w x independently of Gq 51 . Recently it was demonstrated that in neonatal cardiac myocytes Ang II activates p21 Ras in a way analogous to the mechanism used by typical receptor tyrosine kinases like the platelet-derived growth Ž . factor PDGF receptor, i.e., via tyrosine phosphorylation of the linker protein Shc. This will lead to the subsequent Ž association of Shc with the adaptor protein Grb2 growth ( ). factor receptor binding protein-2 and the guanine nuw x Ž . cleotide exchange factor mSOS 98 Fig. 2 . Phosphorylation of the linker protein Shc in response to Ang II stimulation has also been observed in cardiac fibroblasts w x and smooth muscle cells 99,100 . The kinase responsible for the Ang II-induced tyrosine phosphorylation of Shc has not been identified with certainty, but members of the Src family, like Fyn, appear to be the most likely candidates w x 26,98 .
Whatever the exact link may be, cardiac specific overexpression of p21 Ras in transgenic mice has been shown w x to be associated with ventricular hypertrophy 101 . However, this does not necessarily mean that under pathological conditions p21 Ras is critical for the development of cardiac hypertrophy. Recent studies by Abdellatif and w x coworkers 102 suggest that p21 Ras has a global effect on gene expression, rather than being responsible for the induction of the fetal gene program, which is considered a hallmark of the hypertrophic phenotype. Recent data suggest that this general effect on global gene expression is mediated by the phosphorylation of RNA polymerase II Ž . tensive cross-talk between Ang II and cytokine-mediated signaling at the level of MAPK and STAT phosphorylation. As discussed in more detail below the JAK-STAT pathway is also operative in cardiomyocytes.
Signaling through cytokine receptors
One of the most exciting developments in the research on cardiovascular signaling concerns the role of cytokines as paracrine factors and the elucidation of cytokine recep-Ž tor function and its downstream signaling pathways Ref. w x . 111 for review . The potential significance of the production of pro-inflammatory cytokines in cardiovascular disw x eases 112,113 and their effects on cardiac muscle funcw x tion 114 has been appreciated for a number of years. However, an important milestone in realizing that cytokines play an important role in cardiac signaling came from the observation that conditioned medium from embryoid bodies contained a factor that acted as a potent stimulus for the induction of hypertrophy in neonatal w x cardiac myocytes 115 . Expression cloning strategies led to the identification of a protein, referred to as Car-Ž . diotrophin 1 CT-1 , the amino acid sequence of which is Ž . highly homologous to interleukins IL and Leukemia In-Ž . hibitory Factor LIF .
Signaling through cytokine receptors involves gp130, which acts as a signal-transducing receptor component Ž . Fig. 2 . Binding of ligands to the cytokine receptors results in the formation of receptor complexes, of which gp130 forms an essential part. Gp130 itself possesses no intrinsic tyrosine kinase activity, but following its dimerization with cytokine receptors associated tyrosine kinases, like the JAKs, gp130 becomes activated. In turn, the JAKs will phosphorylate and activate their substrates, members w x of the STAT family 111 . Interestingly a number of studies indicate that the Ras-Raf-MAPKK-MAPK pathway is also activated following cytokine receptor activaw x tion 116,117 . The activation of this pathway through cytokine receptors also involves gp130, but the nature of the link between gp130 and Ras is less well understood. Using transgenic and knockout technologies the importance of gp130 in cardiac growth has been demonstrated. Knockout mice that are deficient in gp130 display a hypoplastic development of the ventricular compartment, rew x sulting in premature death 118 . Conversely, in mice overexpressing IL-6 as well as its receptor, gp130 is continuously active. These double transgenic mice a charw x acterized by a marked hypertrophy of the heart 119 .
Administration of CT-1 to neonatal cardiac myocytes w x resulted in cardiomyocyte hypertrophy 120,121 . Similar findings were observed when LIF was applied to these w x cells 122 . It should be noted that at the gene level CT-1 induced a different kind of hypertrophic phenotype than that elicited by 'classical' hypertrophic stimuli, such as a-adrenergic agonists, ET-1, or Ang II. Stimulation with ( )cytokines did not result in an enhanced expression of Ž . skeletal a-actin, b-myosin heavy chain bMHC or the ventricular isoform of myosin light chain-2, but induction of expression of the hypertrophic marker ANF still occurred. Moreover, IL-1b was found to attenuate upregulation of bMHC expression as induced by the a -adrenergic 1 w x agonist phenylephrine 123 .
CT-1 signaling in neonatal cardiomyocytes has been shown to involve the heterodimerization of gp130 and the w x LIF-receptor 121,124 , which leads to the activation of the JAKrSTAT pathway and of the MAPK pathway. Recent findings strongly suggest that each of these two pathways might be involved in different processes. Sheng and w x coworkers 117 provided evidence that CT-1 mediated activation of the JAKrSTAT pathway is most likely involved in the hypertrophic response, whereas CT-1 mediated MAPK activation inhibits apoptosis of cardiomyocytes. Together, these recent findings have provided important clues as to the importance of cytokine-mediated signaling in the cardiovascular system.
Stress-activated protein kinases
Recently a new group of serinerthreonine kinases has w x been identified 125 . These kinases are related to MAPK and are referred to as Stress-Activated Protein Kinases Using cultured neonatal cardiomyocytes as a model system it was shown that the reoxygenation event, rather than the preceding hypoxic episode, provides the stimulus w x for SAPKrJNK activation 129 . Comparable observations were made with isolated rat hearts subjected to ischemia w x and reperfusion 130 . Circumstantial evidence indicated that reactive oxygen species, generated during reoxygenation were involved in this response. It has also been shown that the imposition of an osmotic stress on cardiomyocytes w x activates SAPKrJNK 131 . This observation fits with the idea that transcellular fluid shifts, associated with reperfusion of previously ischemic tissue, provide a trigger for SAPKrJNK activation. Recently, it was shown that Ang II administration to neonatal cardiomyocytes resulted in a rapid activation of SAPKrJNK in a manner that involved the AT receptor and required both PKC activity and 1 2q w x elevation of intracellular Ca levels 132 . Mechanical stretch was also found to activate SAPKrJNK, but unlike the activation of MAPK, this response appeared to be Ang w x II-independent 133 . Furthermore, a -adrenergic stimula-1 tion was also associated with increased SAPKrJNK activity. In this case the activation of SAPKrJNK appeared to w x be p21 Ras dependent 134 . Recently it was observed that the lipid second messenger ceramide also mediated w x SAPKrJNK activation 135 . The role of ceramide in signal transduction is potentially of great importance as it has been shown to modulate a variety of cellular responses, including cell differentiation and apoptosis w x 136,137 . Although only recently discovered, the assembled data already indicate that the SAPKrJNK pathway may be very relevant to the adaptation of the cardiovascular system in response to disturbances in cardiovascular homeostasis.
Conclusions
Since the publication of the spotlight issue in this journal in the fall of 1995 a number of exciting new developments have taken place, only a selection of which have been highlighted. This review mainly focused on the role of Ang II mediated signaling pathways as the deciphering of the downstream signaling cascades has progressed a lot over the last years. Accordingly, Ang IImediated signaling provided a good example to illustrate the complexity of the downstream signaling cascades, with respect to both the number of cascades involved and their interrelationships. However, this does not imply that other peptide growth factors are of less relevance. Signaling through the endothelin-1 and Insulin-like growth factor 1 Ž . IGF-1 receptors will probably prove to be of equal w x biological importance for the cardiovascular system 138 . In fact the potential beneficial effects of the growth horw x mone-IGF-1 axis in relieving cardiac failure 139 , and the therapeutic effects of endothelin-1 receptor antagonists w x 140 , are currently receiving widespread attention in cardiac research.
The ongoing development of new cell biological and molecular techniques will further accelerate the elucidation of components of signaling cascades and the mutual interactions between signaling pathways. In this respect the recent development of new cloning techniques based on w x protein-protein interaction will be fruitful 141 . Furthermore, especially research on cardiac cell signaling has been hampered by the inability to use isolated adult cardiomyocytes as a model system as a result of which most ( )studies concerning signal transduction during the hypertrophic response have been performed with neonatal myocytes. Although important concepts and clues have been Ž . and are still being obtained with this model system, extrapolation of findings from the neonatal to the adult phenotype is not without risk. However, the establishment Ž . of culture conditions composition of the medium, pacing that allow isolated adult myocytes to maintain their differw x entiated phenotype for extended periods of time 142,143 , in combination with Adenoviral transfection techniques that result in a nearly 100% transfection efficiency of w x neonatal as well as adult myocytes 144 , will bridge this gap in the years to come. Finally, transgene and gene knock-out strategies in mice have already provided important information about the biological significance of particular proteins involved in signal transduction, and about counter-regulatory mechanisms that are operative to maintain cardiovascular homeostasis. The advent of physiological techniques that allow in vivo and ex vivo manipulation andror functional analysis of the murine cardiovascular system is likely to fuel future research into the biological significance of signal transduction pathways in the vessel wall and heart, and will allow the testing of leads obtained with cellular model systems in an integrated system.
In view of the substantial progress that has already been made within the last couple of years, it will be interesting to see to what extent the black box of cardiovascular signal transduction has been opened at the start of the next millennium. 
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